Searched over 200M research papers
5 papers analyzed
These studies suggest hyperlipidemia can cause neurological issues, xanthomatosis, atheromatosis, abnormal glucose tolerance, dizziness, chest fullness, shortness of breath, tiredness, weight gain, and painful small-fiber neuropathy in feet.
20 papers analyzed
Hyperlipidemia is a condition characterized by elevated levels of lipids in the blood, including triglycerides, cholesterol, and lipoproteins such as low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL), with a concurrent reduction in high-density lipoprotein (HDL) levels. This condition can be primary, due to genetic factors, or secondary, resulting from other diseases or lifestyle factors.
In the early stages of hyperlipidemia, patients often do not exhibit any noticeable symptoms. This asymptomatic nature makes early detection challenging without routine blood tests.
As hyperlipidemia progresses, several symptoms may become apparent:
Although rare, hyperlipidemia can lead to neurological manifestations. These may include spastic-atactic syndromes and painful polyneuropathy, characterized by pain in the feet without proximal extension or involvement of the hands. Some patients may experience decreased ankle reflexes, while others maintain normal tendon reflexes .
Hyperlipidemia is a significant risk factor for cardiovascular diseases. Symptoms related to cardiovascular issues include dizziness, chest fullness, shortness of breath, and general fatigue. These symptoms are often more pronounced in elderly patients.
Xanthomatosis, the formation of fatty deposits under the skin, is a notable dermatological symptom of hyperlipidemia. These deposits can appear as yellowish patches on the skin, particularly around the eyes, elbows, and knees.
Patients with hyperlipidemia may also exhibit signs of abnormal glucose tolerance, which can be an indicator of concurrent metabolic disorders such as diabetes.
Hyperlipidemia is a complex condition with a range of potential symptoms, from asymptomatic early stages to more pronounced neurological, cardiovascular, dermatological, and metabolic manifestations as the condition progresses. Early detection through routine blood tests is crucial for managing and mitigating the risks associated with hyperlipidemia.
Most relevant research papers on this topic